Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute (NCI)
Grant: P01CA275740
National Cancer Institute (NCI)
Grant: R01CA230561
National Cancer Institute (NCI)
Grant: R01CA244993
NIH HHS
Grant: 5R01CA230561-05A1
NIH HHS
Grant: 5R01CA244993-05A1
NIH HHS
Grant: 1P01CA275740-01A1
National Institutes of Health
Grant: 1R01CA244993-01
Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma
National Institutes of Health
Grant: 5R01CA230561-02
Targeting oncogenes for hepatocellular carcinoma
FWCI
3.64
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals